G. Enas

2011

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Whom G. Enas trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Niko Speybroeck

Who trusts G. Enas overall

  1. Jared C. Foster
  2. Kyle Humphrey

Papers from G. Enas's perspective

Ordered by how strongly the researchers G. Enas trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. (Journal of Clinical Oncology)
  2. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. (New England Journal of Medicine)
  3. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. (New England Journal of Medicine)
  4. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. (New England Journal of Medicine)
  5. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. (Journal of Clinical Oncology)
  6. Bump hunting in high-dimensional data
  7. The method of minimization for allocation to clinical trials. a review. (Controlled Clinical Trials)
  8. Multiple Comparison Procedures
  9. Classification and regression trees
  10. Classification and Regression Trees

Their papers